All articles tagged with #scientific publishing
A weekend reads roundup from Retraction Watch highlights a second death in a Chinese gene-therapy trial, the resignation of Cambridge professor Jason Arday amid plagiarism allegations, and Retraction Watch’s 16th birthday, alongside extensive coverage of data integrity, paper mills, AI-related misconduct, and global debates about trust in scholarly publishing.
Generative AI accelerates the publish-or-perish pressure by enabling rapid fabrication of papers, with detectors often lagging behind increasingly convincing AI-made content. While disclosure norms and screening tools help, experts say the core fix is systemic: reward quality over quantity, adopt data attestations and provenance standards, and align funders, institutions, and publishers to slow AI-enabled fraud. Detection buys time, but meaningful reform requires changing the incentives that drive researchers to publish large volumes.
Beijing is weighing reforms to reduce the weight of publishing in international journals (SCI-indexed) in academic promotions to address national-security concerns about leaks, potentially boosting Chinese journals and tightening oversight of cross-border scientific exchange amid rising US-China tensions.
Biology Open piloted a Fast & Fair program that pays reviewers £220 for high-quality reviews delivered within four working days. The scheme cut the average time to a first editorial decision from about 38 days to 5.5 working days and reportedly improved review usefulness. Funded by The Company of Biologists, the trial expanded to all ten editors in 2025 with pre-contracted reviewers, and authors can opt for traditional peer review if suitably expert reviewers aren’t available. The program is evaluated annually through 2026.
Retraction Watch’s Weekend Reads roundup highlights the White House's plan to tighten grant oversight and ban federal funding for open-access fees, sleuths’ claims that Thermo Fisher doctored data to sell antibodies, debates in China about Nature’s reputation amid AI-generated cover edits, and a broad slate of integrity and publishing stories—from peer-review issues and funding incentives to data-management reforms—plus resources like the Retraction Watch Database and the Ctrl-Z Award.
A five-LLM AI coach, called Review Feedback Agent, was developed to help peer reviewers deliver more specific, constructive, and less toxic feedback. When tested on thousands of existing reviews, it frequently suggested actionable ways to improve comments. It remains unclear whether this improves the quality or impact of the papers being reviewed, requiring further study.
Two large analyses find that critical posts on X often appear before scientific papers are retracted, with 8.3% of retracted studies having a critical tweet before retraction versus 1.5% of non-retracted ones; negative sentiment and the use of red-flag terms correlated with faster retractions, though causality isn’t proven. The work highlights post-publication commentary as a tool to flag potential issues, while cautioning that online critiques can reflect biases and require verification before action.
A survey of 1,600 researchers across 111 countries reveals that over half now use AI for peer review, often against guidelines, with many employing it to assist in writing reports, summarizing manuscripts, and detecting misconduct. Despite its growing use, concerns about confidentiality, accuracy, and the need for responsible implementation persist, prompting publishers like Frontiers to develop policies and in-house AI tools. Experiments show AI can mimic review structure but lacks the ability to provide constructive feedback or detailed critique, highlighting both the potential and limitations of AI in peer review.
The article discusses the issue of unprofessional and bullying behavior in peer review, highlighting its impact on scientists, especially early-career researchers and marginalized groups, and offers strategies for authors to recognize, address, and push back against such conduct to improve scientific communication and integrity.
The article explores how evolutionary pressures influence scientific publishing, highlighting issues like 'publish or perish,' the impact of metrics like h-index, the shift to open access models, and the potential for negative outcomes such as fraud and low-quality research, emphasizing the need to redesign the system for better scientific progress.
An investigation uncovered over 1,500 research articles linked to a Ukrainian network, Tanu.pro, which is suspected of producing fake or low-quality papers and selling authorships, highlighting a significant issue of scientific misconduct in academic publishing.
A new AI system developed by the University of Colorado automatically screens open-access journals to identify potentially predatory publications, flagging over 1,000 suspicious journals out of 15,200 analyzed. While not perfect, it serves as a crucial first filter to help protect scientific credibility, with human experts making the final decisions.
A study from Northwestern University reveals that research fraud in scientific papers is widespread and increasing, with estimates suggesting actual fraud rates could be 10 to 100 times higher than detected. The rise is driven by paper mills, corrupt editors, and the pressure to publish, with the problem exacerbated by online publishing and the potential of generative AI to produce fake research. Experts call for collective action, accountability, and stricter enforcement to combat this growing threat to scientific integrity.
The article discusses the challenges facing scientific publishing, including the overwhelming volume of papers, the rise of AI-generated errors, issues with quality and trust, and the need for reform in incentives and review processes to ensure meaningful scientific progress.
Robert F Kennedy Jr threatens to ban US government scientists from publishing in top medical journals, accusing them of being controlled by pharmaceutical companies, and plans to establish government-run journals to replace them, amid broader concerns about pharmaceutical influence and funding cuts affecting scientific research in the US.